Pregnancy Test Kits Market Report 2026

The pregnancy test kits market size has grown strongly in recent years. It will grow from $1.87 billion in 2025 to $1.98 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increased awareness of reproductive health, widespread availability of OTC diagnostic products, expansion of retail pharmacy networks, rising use of home-based testing, improvements in hcg detection sensitivity.

The pregnancy test kits market size is expected to see strong growth in the next few years. It will grow to $2.6 billion in 2030 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to increasing demand for connected health diagnostics, rising focus on women’s health technologies, expansion of telehealth-supported testing, growing adoption of digital readout tests, increasing emphasis on sustainability in diagnostic products. Major trends in the forecast period include increasing adoption of digital pregnancy test kits, rising demand for early and accurate detection, growing preference for at-home diagnostic solutions, expansion of online distribution channels, enhanced focus on user-friendly test design.

The increasing adoption of telehealth is expected to drive the growth of the pregnancy test kits market in the coming years. Telehealth adoption refers to the expanding use of digital communication technologies that enable healthcare providers and patients to deliver and receive medical services remotely. The rise in telehealth usage is largely attributed to cost efficiency, as virtual consultations help reduce healthcare delivery expenses by minimizing hospital visits, lowering infrastructure requirements, and decreasing related patient costs. Pregnancy test kits complement telehealth adoption by facilitating early at-home pregnancy detection, allowing users to promptly share test results with healthcare providers during teleconsultations and obtain timely medical advice, follow-up care, or prescriptions without the need for in-person visits. For example, in September 2024, according to the Australian Bureau of Statistics (ABS), Australia’s national statistical agency, 83.5% of males reported using telehealth services in 2023-24, up from 78.6% in 2022-23. Therefore, the growing adoption of telehealth is contributing to the expansion of the pregnancy test kits market.

Rising infertility rates are also expected to propel the growth of the pregnancy test kits market going forward. Infertility rates indicate the proportion of couples or individuals of reproductive age who are unable to achieve pregnancy after 12 months of regular, unprotected intercourse. The increase in infertility is partly linked to lifestyle-related factors such as unhealthy diets, obesity, smoking, and stress, all of which can disrupt hormonal balance and negatively affect reproductive health. Pregnancy test kits support infertility management by enabling early detection of conception or helping identify challenges in conceiving, thereby allowing individuals and healthcare professionals to pursue timely fertility assessment and treatment. For instance, in April 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, approximately 17.5% of the global adult population, or about one in six people worldwide, experience infertility, underscoring the urgent need to expand access to affordable and high-quality fertility care. Consequently, the increasing prevalence of infertility is driving the growth of the pregnancy test kits market.

Leading companies operating in the pregnancy test kits market are concentrating on the development of innovative solutions, such as saliva-based pregnancy tests, to improve user convenience, offer non-invasive testing options, and enhance early detection accuracy. A saliva-based pregnancy test is a diagnostic product that identifies pregnancy by analyzing saliva samples for the presence of human chorionic gonadotropin (hCG), the hormone produced during early pregnancy, providing a convenient alternative to conventional urine-based tests. For example, in June 2023, Salignostics Ltd., an Israel-based biotechnology company, introduced Salistick, a non-invasive saliva-based pregnancy testing solution. The test detects β-hCG with more than 96% accuracy as early as one day after a missed period. Its advantages include eliminating the need for urine collection, enabling hygienic and private testing in any location without bathroom access, and delivering results within 5-15 minutes using a simple foam stick, thereby offering reliable performance comparable to traditional pregnancy tests while enhancing user comfort and accessibility in global at-home diagnostics.

Major companies operating in the pregnancy test kits market are Johnson & Johnson, Procter & Gamble Co, Abbott Laboratories, Church & Dwight Co Inc, Alere Inc, Piramal Enterprises Ltd, Quidel Corporation, Mankind Pharma, Cardinal Health Inc, EKF Diagnostics Holdings PLC, Sugentech Inc, Egens Group, INTEC Group, Medsource Ozone Biomedicals, SPD Swiss Precision Diagnostics, Geratherm Medical AG, Princeton BioMeditech Corporation, Cupid Limited, Easy Healthcare Corporation, Axis Medicare Ltd, AccuQuik Test Kits, Sara Health Care Pvt Ltd, Hicks Thermometers India Limited, Fairhaven Health LLC.

North America was the largest region in the pregnancy test kits market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pregnancy test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pregnancy test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the pregnancy test kits market by increasing costs of imported reagents, biosensors, plastic casings, electronic display components, and packaging materials. Manufacturers in North America and Europe are most affected due to dependence on globally sourced raw materials, while Asia-Pacific faces cost pressures in mass production and exports. These tariffs are increasing product prices and affecting retail margins. However, they are also encouraging domestic manufacturing, localized sourcing of components, and innovation in cost-effective and sustainable test kit designs.

The pregnancy test kits market research report is one of a series of new reports that provides pregnancy test kits market statistics, including pregnancy test kits industry global market size, regional shares, competitors with a pregnancy test kits market share, detailed pregnancy test kits market segments, market trends and opportunities, and any further data you may need to thrive in the pregnancy test kits industry. This pregnancy test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pregnancy test kits are easy-to-use, over-the-counter diagnostic tools developed to detect the presence of the hormone human chorionic gonadotropin (hCG) in a woman’s urine, which is a primary indicator of early pregnancy. These kits are designed for convenience and simplicity, enabling women to perform testing privately at home by following straightforward instructions.

The main categories of pregnancy test kits include blood tests for human chorionic gonadotropin (hCG) and urine tests for human chorionic gonadotropin (hCG). Blood-based hCG tests are laboratory diagnostic procedures that quantify the level of the hCG hormone in the bloodstream. hCG is mainly produced by the placenta shortly after implantation of a fertilized egg in the uterus, making it an essential marker for the detection and monitoring of pregnancy. These kits are distributed through multiple channels, including retail outlets and online platforms, and are used across settings such as hospitals, clinics, households, and pharmacies, serving end-users that include healthcare professionals as well as home-based users.

The pregnancy test kits market consists of sales of laboratory-based pregnancy test kits, home-use pregnancy test kits, clinical pregnancy detection kits and over-the-counter pregnancy test kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.